Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey
Shirley Shapiro Ben David, Naama Shamir-Stein, Sharon Baruch Gez, Uri Lerner, Daniella Rahamim-Cohen, Anat Zohar
Topics & Concepts
ReactogenicityMedicinemyalgiaCoronavirus disease 2019 (COVID-19)Booster (rocketry)CohortFamily medicineImmunogenicityInternal medicineImmunologyInfectious disease (medical specialty)DiseaseAstronomyPhysicsImmune systemSARS-CoV-2 and COVID-19 ResearchLymphadenopathy Diagnosis and AnalysisImmune responses and vaccinations